← Back to Screener
AgomAb Therapeutics NV American Depositary Shares (AGMB)
Price$9.92
Momentum ScoreC
Favorite Metrics
Price vs S&P 500 (4W)0.63%
VGM Score48.76
Market Capitalization$670.17M
All Metrics
Indicated Dividend (Annual)$0.00
Price vs S&P 500 (YTD)-28.46%
EPS (TTM)$-1.48
10-Day Avg Trading Volume0.06M
EPS Excl Extra (TTM)$-1.48
EPS (Annual)$-1.48
ROI (Annual)-47.33%
Cash / Share (Quarterly)$0.00
ROA (Last FY)-40.69%
EBITD / Share (TTM)$-1.40
Cash Flow / Share (Annual)$-0.00
P/B Ratio3.84x
Net Income / Employee (Annual)$-1,166,670
Net Interest Coverage (TTM)-17.59x
EPS Incl Extra (Annual)$-1.48
Current Ratio (Annual)6.52x
Quick Ratio (Quarterly)6.52x
3-Month Avg Trading Volume0.17M
Revenue / Employee (TTM)$0
52-Week High$17.45
EPS Excl Extra (Annual)$-1.48
Quick Ratio (Annual)6.52x
13-Week Price Return-19.01%
Total Debt / Equity (Annual)0.01x
Current Ratio (Quarterly)6.52x
Revenue / Employee (Annual)$0
Cash / Share (Annual)$0.00
3-Month Return Std Dev79.82%
Net Income / Employee (TTM)$-1,166,670
ROE (Last FY)-47.78%
EPS Basic Excl Extra (Annual)$-1.48
Total Debt / Equity (Quarterly)0.01x
EPS Incl Extra (TTM)$-1.48
Revenue / Share (Annual)$0.00
Year-to-Date Return-18.84%
5-Day Price Return5.69%
EPS Normalized (Annual)$-1.48
Month-to-Date Return5.69%
EBITD / Share (Annual)$-1.40
LT Debt / Equity (Annual)0.00x
EPS Basic Excl Extra (TTM)$-1.48
Price vs S&P 500 (13W)-29.51%
Beta1.89x
Revenue / Share (TTM)$0.00
52-Week Low$9.00
mGradeC
vgmGradeC
Show chart for
Analyst Recommendations
Apr 2026
May 2026
Jun 2026
4.30
4.30
4.30
Industry Peers — Biological Products(178)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
AGMBAgomAb Therapeutics NV American Depositary Shares | — | — | C | $9.92 |
| AMGNAmgen Inc | C | C | C | $349.58 |
| GILDGilead Sciences Inc | C | B | C | $129.16 |
| ARGXargenx SE American Depositary Shares | D | A | B | $891.32 |
| RVMDRevolution Medicines, Inc. Common Stock | F | — | A | $149.23 |
| BIIBBiogen Inc. Common Stock | B | D | B | $195.34 |
| BNTXBioNTech SE American Depositary Share | C | C | D | $88.08 |
| MRNAModerna, Inc. Common Stock | C | B | B | $47.44 |
| NBIXNeurocrine Biosciences Inc | C | B | B | $163.88 |
| EXELExelixis Inc | C | B | B | $52.70 |
| KRYSKrystal Biotech, Inc. Common Stock | D | B | A | $301.00 |
About
AgomAb Therapeutics is a clinical-stage biopharmaceutical company developing small molecule and antibody therapies for chronic fibrotic diseases and related immunological disorders with significant unmet medical needs. The company's pipeline targets established inflammatory pathways using validated modalities, with lead candidates Ontunisertib (AGMB-129) and AGMB-447. AgomAb's approach aims to overcome limitations of existing treatment options for fibrotic indications.